ATE397939T1 - Stabilisierte flüssigzubereitung der den blutgerinnungsfaktor vii aktivierenden protease oder ihres proenzyms - Google Patents
Stabilisierte flüssigzubereitung der den blutgerinnungsfaktor vii aktivierenden protease oder ihres proenzymsInfo
- Publication number
- ATE397939T1 ATE397939T1 AT01129605T AT01129605T ATE397939T1 AT E397939 T1 ATE397939 T1 AT E397939T1 AT 01129605 T AT01129605 T AT 01129605T AT 01129605 T AT01129605 T AT 01129605T AT E397939 T1 ATE397939 T1 AT E397939T1
- Authority
- AT
- Austria
- Prior art keywords
- factor vii
- stabilized liquid
- proenzyme
- liquid preparation
- blood clotting
- Prior art date
Links
- 108010062466 Enzyme Precursors Proteins 0.000 title abstract 3
- 102000010911 Enzyme Precursors Human genes 0.000 title abstract 3
- 108091005804 Peptidases Proteins 0.000 title abstract 3
- 239000004365 Protease Substances 0.000 title abstract 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 title abstract 3
- 239000003114 blood coagulation factor Substances 0.000 title 1
- 229940012413 factor vii Drugs 0.000 title 1
- 239000007788 liquid Substances 0.000 title 1
- 108010023321 Factor VII Proteins 0.000 abstract 2
- 230000003213 activating effect Effects 0.000 abstract 2
- 235000001014 amino acid Nutrition 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 abstract 2
- BPMFZUMJYQTVII-UHFFFAOYSA-N guanidinoacetic acid Chemical compound NC(=N)NCC(O)=O BPMFZUMJYQTVII-UHFFFAOYSA-N 0.000 abstract 2
- 239000012669 liquid formulation Substances 0.000 abstract 2
- GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 abstract 1
- QYPPJABKJHAVHS-UHFFFAOYSA-N Agmatine Natural products NCCCCNC(N)=N QYPPJABKJHAVHS-UHFFFAOYSA-N 0.000 abstract 1
- KDZOASGQNOPSCU-WDSKDSINSA-N Argininosuccinic acid Chemical compound OC(=O)[C@@H](N)CCC\N=C(/N)N[C@H](C(O)=O)CC(O)=O KDZOASGQNOPSCU-WDSKDSINSA-N 0.000 abstract 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 abstract 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 abstract 1
- JRLGPAXAGHMNOL-LURJTMIESA-N N(2)-acetyl-L-ornithine Chemical compound CC(=O)N[C@H](C([O-])=O)CCC[NH3+] JRLGPAXAGHMNOL-LURJTMIESA-N 0.000 abstract 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 abstract 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 abstract 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 abstract 1
- QYPPJABKJHAVHS-UHFFFAOYSA-P agmatinium(2+) Chemical compound NC(=[NH2+])NCCCC[NH3+] QYPPJABKJHAVHS-UHFFFAOYSA-P 0.000 abstract 1
- 229960002684 aminocaproic acid Drugs 0.000 abstract 1
- 229960002173 citrulline Drugs 0.000 abstract 1
- 235000013477 citrulline Nutrition 0.000 abstract 1
- 229960003624 creatine Drugs 0.000 abstract 1
- 239000006046 creatine Substances 0.000 abstract 1
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 abstract 1
- 229960003104 ornithine Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 abstract 1
- 229960000401 tranexamic acid Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10100483 | 2001-01-08 | ||
| DE10131404A DE10131404A1 (de) | 2001-01-08 | 2001-06-25 | Stabilisierte Flüssigzubereitung für den Blutgerinnungsfaktor VII aktivierenden Protease oder ihres Proenzyms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE397939T1 true ATE397939T1 (de) | 2008-07-15 |
Family
ID=7669938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01129605T ATE397939T1 (de) | 2001-01-08 | 2001-12-12 | Stabilisierte flüssigzubereitung der den blutgerinnungsfaktor vii aktivierenden protease oder ihres proenzyms |
Country Status (3)
| Country | Link |
|---|---|
| AT (1) | ATE397939T1 (de) |
| DE (1) | DE10131404A1 (de) |
| ES (1) | ES2307561T3 (de) |
-
2001
- 2001-06-25 DE DE10131404A patent/DE10131404A1/de not_active Withdrawn
- 2001-12-12 AT AT01129605T patent/ATE397939T1/de active
- 2001-12-12 ES ES01129605T patent/ES2307561T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE10131404A1 (de) | 2002-07-11 |
| ES2307561T3 (es) | 2008-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1113353T1 (el) | Φαρμακοτεχνικη μορφη αντι-τνf-αλφα αντισωματος | |
| EP1226829A3 (de) | Stabilisierte Flüssigzubereitung der den Blutgerinnungsfaktor VII aktivierenden Protease oder ihres Proenzyms | |
| DE69805772D1 (de) | Stabilisierte mischung auf fibrinogenbasis | |
| CY1110516T1 (el) | Αναστρεψιμα απενεργοποιημενη οξινισμενη πλασμινη | |
| ATE375142T1 (de) | Medizinische aerosolformulierungen | |
| DK0558529T3 (da) | Farmaceutisk præparat til behandling af forlænget koagulationstid | |
| ATE254928T1 (de) | Stabilisierte zusammensetzung mit nootropen wirkstoffen | |
| NO2013003I2 (no) | Forbindelser som NS3-serinproteaseinhibitorer for hepatitt C-virus, farmasøytiske preparater og anvendelse av forbindelsene til fremstilling av et medikament | |
| SE0100901D0 (sv) | New composition | |
| BRPI0408439A (pt) | composição farmacêutica lìquida aquosa, método para preparar e uso da mesma, método para tratar uma sìndrome responsiva ao fator vii, e, recipiente hermético | |
| ES2139740T3 (es) | Cola de fibrina de dos componentes. | |
| SE0002202D0 (sv) | New peptides | |
| DE50005529D1 (de) | Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac | |
| DE69932860D1 (de) | Verwendung von l-carnitin und seinen alkanoyl-derivaten als osmotisches mittel in lösungen für medizinische verwendung | |
| DE502004011851D1 (de) | Caspase 3, 8, 9 oder 10 Inhibitoren in Kombination mit MEK Inhibitoren zur Behandlung von Influenza | |
| TW337997B (en) | Pharmaceutical preparation containing plasminogen activators | |
| ATE256392T1 (de) | Verwendung von polyaminosäurederivate als konservierungsmittel | |
| DK1648496T3 (da) | Fremgangsmåde til stabilisering af et kryopræcipitat af plasmatiske proteiner, som er beregnet til at udsættes for en varmebehandling til virusinaktivering | |
| DE50203283D1 (de) | Zubereitung zur entfernung von abnormen keratinmaterial | |
| FR2773712B1 (fr) | Composition pharmaceutique comprenant au moins un inhibiteur de l'aminopeptidase a | |
| ATE397939T1 (de) | Stabilisierte flüssigzubereitung der den blutgerinnungsfaktor vii aktivierenden protease oder ihres proenzyms | |
| ATE395064T1 (de) | Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen | |
| GB9930768D0 (en) | Composition | |
| DE50111407D1 (de) | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen | |
| WO2003028654A3 (en) | Storage-stable human fibrinogen solutions |